Detection of certain auto-antibodies flagged patients with scleroderma (also known as systemic sclerosis) who were especially likely to develop pulmonary hypertension over long-term follow-up, a ...

Pulmonary arterial hypertension (PAH), a common complication of systemic sclerosis, carries a very severe prognosis and is one of the leading causes of death in patients who suffer from it. Indeed, ...

Please provide your email address to receive an email when new articles are posted on . CLEVELAND — Every patient with systemic sclerosis should be screened for pulmonary arterial hypertension every ...

Screening for a sometimes fatal condition among patients with a rare autoimmune disease could soon - thanks to a computer algorithm - become even more accurate. Researchers at Michigan Medicine found ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Among them: scleroderma, lupus, rheumatoid arthritis, dermatomyositis, polymyositis, and Sjogren's syndrome, said Stephen Mathai, MD, of Johns Hopkins University in Baltimore, speaking at the American ...

Researchers have discovered a protein that may predict disease severity for a lung condition that often proves fatal to patients with scleroderma. The recent study, published in Arthritis Care & ...

Screening for a sometimes fatal condition among patients with a rare autoimmune disease could soon - thanks to a computer algorithm - become even more accurate. Researchers at Michigan Medicine found ...

Systemic sclerosis (SSc), also referred to as scleroderma, is a rare autoimmune disease associated with vasculopathy, inflammation, and fibrosis of the skin and/or internal organs. Interstitial lung ...

PHILADELPHIA (WPVI) -- When a rare disease strikes, getting a diagnosis can take years, enabling the disease to progress. A young woman from the Mayfair section of Philadelphia details her battle to ...

Boehringer Ingelheim is looking to expand its compound nintedanib to treat some scleroderma patients. And in preparation, it’s looking to expand awareness about the disease, too. The company recently ...

Scleroderma-related PAH remains a syndrome that is difficult to treat with currently available medical therapy, for reasons that are poorly understood. Although classified within the group 1 (PAH) of ...